Literature DB >> 1231967

Immediate haemodynamic effects of verapamil in man.

B S Lewis, A S Mitha, M S Gotsman.   

Abstract

The effect of the antiarrhythmic drug verapamil (Isoptin) on circulatory dynamics and myocardial contractility was studied in six patients in sinus rhythm: three patients were control subjects and three had underlying rheumatic valvular disease. The drug was given as an intravenous bolus (10 mg) and measurements made in the control state and repeated 1, 3, 5 and 10 min after administration of verapamil. Left ventricular (LV) systolic pressure fell by 18% 1 min after intravenous verapamil (p less than 0.01) and returned twoards the range of normal after 10 min. Heart rate increased and cardiac and stroke index were not altered 5 and 10 min after administration of the drug. Peak LVdp/dt and Vmax were reduced while LV end-diastolic pressure increased reflecting a decrease in LV contractility. The hemodynamic effects were similar in digitalised and nondigitalised patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1231967     DOI: 10.1159/000169736

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  5 in total

1.  Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

Authors:  I L Geft; M M Zion; M Kaltenbach; R Hopf
Journal:  Br Heart J       Date:  1980-06

2.  Newer antiarrhythmic drugs.

Authors:  D Hess
Journal:  West J Med       Date:  1981-04

Review 3.  Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  D McTavish; E M Sorkin
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 4.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

5.  Influence of verapamil on cellular integrity and electrolyte concentrations of ischemic myocardial tissue in the cat.

Authors:  A M Lefer; E W Polansky; C P Bianchi; S Narayan
Journal:  Basic Res Cardiol       Date:  1979 Sep-Oct       Impact factor: 17.165

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.